Because both transcriptional control and post-translational modification influence IGFBP-6 abundance and binding properties, compartment-aware, stimulus-resolved assays are needed to interpret circulating and tissue IGFBP-6 during steatosis, fibrosis, and viral hepatitis. The gene discussed is IGFBP6; the disease is steatosis.